Who owns Neuphoria Therapeutics Inc.?
- Ticker: NEUP
- CUSIP Number: 64136e102
Tip: Access positions for across all investors
Analyze quarterly positions in Neuphoria Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Neuphoria Therapeutics stock
Who bought or sold Neuphoria Therapeutics Inc. this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Lynx1 Capital Management | 875k | $3.4M | 100% | Dec 2025 |
|
| None | 169k | $656k | 100% | Dec 2025 |
|
| AdvisorShares Investments | 134k | $521k | 129% | Dec 2025 |
|
| Diadema Partners | 50k | $194k | 133% | Dec 2025 |
|
| Ikarian Capital | 47k | $184k | 100% | Dec 2025 |
|
| ADAR1 Capital Management | 30k | $116k | 100% | Dec 2025 |
|
| Prosperity Wealth Management | 30k | $352k | 0% | Sep 2025 |
|
| FNY Investment Advisers | 27k | $102k | 100% | Dec 2025 |
|
| Vanguard Group | 21k | $81k | 0% | Dec 2025 |
|
| Millennium Management | 18k | $216k | 100% | Sep 2025 |
|
| Geode Capital Management | 17k | $67k | 33% | Dec 2025 |
|
| Jane Street | 17k | $64k | 6% | Dec 2025 |
|
| Boothbay Fund Management | 14k | $54k | 100% | Dec 2025 |
|
| Persistent Asset Partners | 13k | $52k | 173% | Dec 2025 |
|
| XTX Topco | 12k | $47k | 100% | Dec 2025 |
|
| Commonwealth Equity Services | 11k | $44k | 100% | Dec 2025 |
|
| Merck & Co | 10k | $39k | 0% | Dec 2025 |
|
| UBS Group | 1.7k | $6.4k | -24% | Dec 2025 |
|
| Tower Research Capital | 1.4k | $5.4k | 241% | Dec 2025 |
|
| Rhumbline Advisers | 202.00 | $782.992400 | 512% | Dec 2025 |
|
| FMR | 2.00 | $24.000000 | 100% | Sep 2025 |
|
Who sold out of Neuphoria Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Citadel Advisors | Jun 2025 | 15k | $104k |